We’ve now gone ‘Bang, Bang’ with the first two P2 trials.
Whilst I’m very happy to wait for Angelman results, I’d suggest BP really can’t afford to wait now.
Jon’s imminent US tour couldn’t be better timed with Neuren holding all the cards.
Being able to fund our own P3 trials means any TO offers (and they will come thick and fast) will need to be mighty, mighty compelling…
Neuren Media and Analyst Coverage, page-991
-
- There are more pages in this discussion • 209 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.27 |
Change
0.650(3.15%) |
Mkt cap ! $2.718B | |||
| Open | High | Low | Value | Volume |
| $20.84 | $21.56 | $20.76 | $7.760M | 364.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1378 | $21.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.29 | 218 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |